Vaso Corporation (VASO)
(Delayed Data from OTC)
$0.18 USD
-0.01 (-6.43%)
Updated Oct 3, 2024 01:59 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VASO 0.18 -0.01(-6.43%)
Will VASO be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for VASO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VASO
Top Research Reports for Exxon Mobil, Mastercard and Procter & Gamble
VASO Q2 Earnings Flat Y/Y, Revenues Down, Gross Margin Contracts
VASO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Initiates Coverage of Vaso With Neutral Recommendation
The Zacks Analyst Blog Highlights SAP, Abbott Laboratories, Citigroup, Team and Vaso
Top Analyst Reports for SAP, Abbott Laboratories & Citigroup
Other News for VASO
Vaso announces termination of business combination with Achari Ventures Holdings Corp. I
Vaso Corporation Announces Termination of Business Combination Agreement with Achari Ventures Holdings Corp. I
Vaso Corporation Announces Date Change for Its Stockholders Meeting
Vasomedical reports Q2 results
Vaso Corporation Announces Financial Results for Second Quarter 2024